Prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: a systematic review and meta-analysis

ConclusionsThis meta-analysis found a low prevalence of colistin resistance amongA. baumannii isolates responsible for infections worldwide from 2000 to 2023. However, there is a high prevalence of colistin-resistant isolates in certain countries. This implies an urgent public health threat, as colistin is one of the last antibiotics available for the treatment of infections caused by XDR strains ofA. baumannii.

http://link.springer.com/10.1186/s13756-024-01376-7

Source: Antimicrobial Resistance and Infection Control - February 28, 2024 Category: Infectious Diseases Source Type: research